Skip to main content
ADPT logo

ADPT · Adaptive Biotechnologies Corp · Analyst Estimates

Track ADPT — free
$28.54 -0.37 (-1.26%)
Market Cap
$4.52B
Shares
159.60M
Volume · Oct 1 45.67K Avg daily vol (55 sessions) 2.36M

Analyst Estimates

Compare analyst forecasts for Adaptive Biotechnologies Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 18:49 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.57
-0.54251
-0.51
—
-0.54108
-0.45245
-0.54108
-0.45731
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
7
7
0
0
Revenue
USD
Publication date not stated
290616000
293489920
296875440
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.33
-0.18187
-0.01
—
-0.18473
-0.237
-0.18473
-0.25286
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
2
4
3
Revenue
USD
Publication date not stated
345000000
360441160
371257000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.11
-0.09556
-0.08
—
-0.09556
-0.11188
-0.09556
-0.11344
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
7
7
Revenue
USD
Publication date not stated
70000000
71688380
73400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.08
-0.06413
-0.04
—
-0.0627
-0.08189
-0.0627
-0.07877
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
77300000
79243880
83000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
8
— — — — — — — —
Key facts CIK 1478320 CUSIP 00650F109 13F (30d) 9 filings 9 filers Visit website Investor relations